SANGAMO THERAPEUTICS INC (SGMO) Stock Earnings Estimates
NASDAQ:SGMO • US8006771062
0.3869 USD
+0.01 (+2.14%)
At close: Feb 13, 2026
0.398 USD
+0.01 (+2.87%)
After Hours: 2/13/2026, 8:00:01 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 111.3M 0.54% | 176.232M 58.34% | 57.8M -67.20% | 60.568M 4.79% | 49.225M -18.73% | 168.64M 242.59% | 211.34M 25.32% | 409.8M 93.91% | 555.29M 35.50% | 733.79M 32.15% | 882.61M 20.28% | 968.24M 9.70% | |
| EBITDA YoY % growth | -189.2M -8.80% | -87.527M 53.74% | -93.041M -6.30% | -70.04M 24.72% | -110.976M -58.45% | -225.42M -103.13% | 113.32M 150.27% | 234.5M 106.94% | 359.04M 53.11% | N/A | N/A | N/A | |
| EBIT YoY % growth | -201.3M -9.82% | -102.592M 49.04% | -98.148M 4.33% | -85.313M 13.08% | -106.916M -25.32% | -79.424M 25.71% | 33.227M 141.83% | 223.45M 572.50% | 355.44M 59.07% | 491.95M 38.41% | 626.18M 27.29% | 702.32M 12.16% | |
| Operating Margin | -180.86% | -58.21% | -169.81% | -140.85% | -217.20% | -47.10% | 15.72% | 54.53% | 64.01% | 67.04% | 70.95% | 72.54% | |
| EPS YoY % growth | -1.25 -0.81% | -1.47 -17.60% | -0.52 64.63% | -0.34 34.48% | -0.28 17.37% | 0.07 123.55% | 0.16 135.85% | 0.82 425.11% | 1.29 56.52% | 1.74 35.32% | 2.15 23.75% | 2.34 8.77% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.06 44.36% | -0.06 53.86% | -0.06 19.25% | -0.06 44.36% | -0.03 44.45% |
| Revenue Q2Q % growth | 20.706M 174.22% | 20.961M 225.63% | 21.93M 19.80% | 23.103M 3,876.42% | 37.638M 81.77% |
| EBITDA Q2Q % growth | 3.06M 114.65% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 5.559M 121.39% | -14.28M 51.80% | -13.26M 25.74% | -11.22M 68.44% | -7.14M -228.44% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.11 -375.00% | 0.00 | -0.11 | -63,537.14% |
| Q2 2025 Q2Q % growth | -0.08 55.56% | -0.13 | 0.05 | 38.49% |
| Q1 2025 Q2Q % growth | -0.14 48.15% | -0.13 | -0.01 | -5.04% |
| Q4 2024 Q2Q % growth | -0.11 67.65% | -0.09 | -0.02 | -18.18% |
| Q3 2024 Q2Q % growth | 0.04 106.78% | -0.03 | 0.07 | 237.26% |
| Q2 2024 Q2Q % growth | -0.18 72.73% | -0.15 | -0.03 | -21.11% |
| Q1 2024 Q2Q % growth | -0.27 -325.00% | -0.22 | -0.05 | -23.84% |
| Q4 2023 Q2Q % growth | -0.34 -6.25% | -0.26 | -0.08 | -30.10% |
| Q3 2023 Q2Q % growth | -0.59 -73.53% | -0.33 | -0.26 | -80.76% |
| Q2 2023 Q2Q % growth | -0.66 -127.59% | -0.35 | -0.31 | -88.94% |
| Q1 2023 Q2Q % growth | 0.12 140.00% | -0.33 | 0.45 | 135.85% |
| Q4 2022 Q2Q % growth | -0.32 -23.08% | -0.37 | 0.05 | 12.85% |
| Q3 2022 Q2Q % growth | -0.34 -3.03% | -0.36 | 0.02 | 6.22% |
| Q2 2022 Q2Q % growth | -0.29 12.12% | -0.36 | 0.07 | 19.40% |
| Q1 2022 Q2Q % growth | -0.30 6.25% | -0.32 | 0.02 | 5.43% |
| Q4 2021 Q2Q % growth | -0.26 10.34% | -0.35 | 0.09 | 26.21% |
| Q3 2021 Q2Q % growth | -0.33 -3,200.00% | -0.34 | 0.01 | 4.00% |
| Q2 2021 Q2Q % growth | -0.33 -26.92% | -0.32 | -0.01 | -3.45% |
| Q1 2021 Q2Q % growth | -0.32 13.51% | -0.30 | -0.02 | -6.84% |
| Q4 2020 Q2Q % growth | -0.29 | -0.22 | -0.07 | -33.65% |
| Q3 2020 Q2Q % growth | -0.01 | -0.25 | 0.24 | 95.95% |
| Q2 2020 Q2Q % growth | -0.26 | 0.07 | -0.33 | -464.15% |
| Q1 2020 Q2Q % growth | -0.37 | -0.29 | -0.08 | -26.67% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 581K -98.82% | 35.088M | -34.507M | -98.34% |
| Q2 2025 Q2Q % growth | 18.306M 5,042.13% | 32.314M | -14.008M | -43.35% |
| Q1 2025 Q2Q % growth | 6.437M 1,238.25% | 7.565M | -1.128M | -14.91% |
| Q4 2024 Q2Q % growth | 7.551M 269.78% | 13.889M | -6.338M | -45.63% |
| Q3 2024 Q2Q % growth | 49.412M 425.77% | 18.302M | 31.11M | 169.98% |
| Q2 2024 Q2Q % growth | 356K -94.79% | 8.425M | -8.069M | -95.77% |
| Q1 2024 Q2Q % growth | 481K -99.70% | 6.788M | -6.307M | -92.91% |
| Q4 2023 Q2Q % growth | 2.042M -92.49% | 8.267M | -6.225M | -75.30% |
| Q3 2023 Q2Q % growth | 9.398M -64.54% | 10.613M | -1.215M | -11.45% |
| Q2 2023 Q2Q % growth | 6.835M -76.75% | 15.129M | -8.294M | -54.82% |
| Q1 2023 Q2Q % growth | 157.957M 460.13% | 24.546M | 133.411M | 543.51% |
| Q4 2022 Q2Q % growth | 27.2M -2.86% | 27.394M | -194K | -0.71% |
| Q3 2022 Q2Q % growth | 26.5M -7.34% | 27.321M | -821K | -3.01% |
| Q2 2022 Q2Q % growth | 29.4M 5.38% | 25.123M | 4.277M | 17.02% |
| Q1 2022 Q2Q % growth | 28.2M 7.22% | 27.831M | 369K | 1.33% |
| Q4 2021 Q2Q % growth | 28M 8.53% | 27.36M | 640K | 2.34% |
| Q3 2021 Q2Q % growth | 28.6M -50.52% | 25.693M | 2.907M | 11.31% |
| Q2 2021 Q2Q % growth | 27.9M 29.17% | 27.014M | 886K | 3.28% |
| Q1 2021 Q2Q % growth | 26.3M 100.76% | 25.146M | 1.154M | 4.59% |
| Q4 2020 Q2Q % growth | 25.8M | 32.795M | -6.995M | -21.33% |
| Q3 2020 Q2Q % growth | 57.8M | 27.08M | 30.72M | 113.44% |
| Q2 2020 Q2Q % growth | 21.6M | 104.76M | -83.16M | -79.38% |
| Q1 2020 Q2Q % growth | 13.1M | 23.191M | -10.091M | -43.51% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 13.29% | 38.27% | 4.75% | -14.71% |
| Revenue | 0% | 54.02% | 10.68% | -18.43% |